Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction: Data from the GISSI-2 database

Archives of Internal Medicine

Volumn 157, Issue 8, 1997, Pages 865-869

  Moccetti, Tiziano ^a,c   Malacrida, Roberto ^a   Pasotti, Elena ^a   Sessa, Fabrizio ^a   Genoni, Michele ^a   Barlera, Simona ^b   Turazza, Fabio ^b   Maggioni, Aldo P ^b  

^a Civil Hospital   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Ospedale Civico Lugano   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURVIVAL;

EID: 0031403067     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.8.865     Document Type: Article

References (38)

1. World Health Organization. Myocardial Infarction Community Registers: Public Health in Europe, No 5. Copenhagen, Denmark: World Health Organization, Regional Office for Europe; 1976.
2. Hoit BD, Gilpin EA, Henning H, et al. Myocardial infarction in young patients: an analysis by age subsets. Circulation. 1986;74:712-721.
3. Uhl GS, Farrell PW. Myocardial infarction in young adults: risk factors and natural history. Am Heart J. 1983;105:548-553.
4. Chouhan L, Hajar HA, Pomposiello JC. Comparison of thrombolytic therapy for acute myocardial infarction in patients aged <35 and >55 years. Am J Cardiol. 1993;71:157-159.
5. Garg KC, Negi NS, Pathak PK, Agarwal A, Kapur P. Acute myocardial infarction (AMI) in young adults (a study of risk factors and their early clinical course). J Assoc Physicians India. 1987;35:281-284.
6. Bergstrand R, Vedin A, Wilhelmsson C, Wilhelmsen L. Incidence and prognosis of acute myocardial infarction among men below age 40 in Göteborg, Sweden. Eur Heart J. 1982;3:130-135.
7. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
9. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet. 1990;335:427-431.
10. Anglo Scandinavian Study of Early Thrombolysis (ASSET). Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet. 1988;2:525-530.
11. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
12. Kereiakes DJ, Topol EJ, George BS, et al. Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion: the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol. 1991;17:304-312.
13. Barbash GI, White HD, Modan M, et al, for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Acute myocardial infarction in the young: the role of smoking. Eur Heart J. 1995;16:313-316.
14. Gruppo ltaliano per lo Studio della Soprawivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990;336:65-71.
15. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico. Six-month survival in 20 891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Eur Heart J. 1992;13:1692-1697.
16. Killip T, Kimbal JY. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-463.
17. De Vita C, Franzosi MG, Geraci E, et al. GISSI-2: mortality plus extensive left-ventricular damage as 'end-point.' Lancet. 1990;335:289-290.
18. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real time, two-dimensional echocardiography: a comparison of cineangiographic and radionuclide techniques. Circulation. 1972;60:760-766.
19. Wagner GS, Freye CJ, Palmieri ST, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size: specificity and observer agreement. Circulation. 1982;65:342-347.
20. Mauri F, Maggioni AP, Franzosi MG, Santoro E, Tognoni G. A simple ECG predictor of the outcome of patients with AMI treated with a thrombolytic agent: a GISSI-2 derived analysis. J Am Coll Cardiol. 1994;24:600-607.
21. Schlesselman JJ, Stolley PD. Basic methods of analysis. In: Schlesselman JJ, Stolley PD, eds. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:171-226.
22. Schlesselman JJ, Stolley PD. Multivariate analysis. In: Schlesselman JJ, Stolley PD, eds. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:227-290.
23. Harpel P. Blood proteolytic enzyme inhibitors: their role in modulating blood coagulation and fibrinolytic pathways. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Haemostasis and Thrombosis: Basic Principles and Clinical Practice. 2nd ed. Philadelphia, Pa: JB Lippincott Co; 1987:219-234.
24. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-963.
25. The Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
26. Scanu AM, Lawn RM, Berg K. Lipoprotein (a) and atherosclerosis. Ann Intern Med. 1991;115:209-218.
27. Zimmerman FH, Cameron A, Fisher LD, Grace NG. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 1995;26:654-661.
28. Lamm G. The epidemiology of acute myocardial infarction in young age groups. In: Roskamm H, ed. Myocardial Infarction at Young Age. Berlin, Germany: Springer-Verlag; 1981:5-12.
29. La Vecchia C, Franceschi S, DeCarli A, Pampallona S, Tognoni G. Risk factors for myocardial infarction in young women. Am J Epidemiol. 1987;125:832-843.
30. Underwood DA, Proudfit WL, Lim J, MacMillan JP. Symptomatic coronary artery disease in patients aged 21 to 30 years. Am J Cardiol. 1985;55:631-634.
31. Maity AK, Das MK, Chatterjee SS, Dutta S, Guha S. Prognostic significance of risk factors in acute myocardial infarction in young. Indian Heart J. 1989;41:288-291.
32. Weinberger I, Rotenberg Z, Fuchs J, Sagy A, Friedmann J, Agmon J. Myocardial infarction in young adults under 30 years: risk factors and clinical course. Clin Cardiol. 1987;10:9-15.
33. Glover MU, Huber MT, Warren SE, Vieweg WVR. Myocardial infarction before age 36: risk factor and arteriographic analysis. Am J Cardiol. 1982;48:1600-1603.
34. Wolfe MW, Vaeek JL. Myocardial infarction in young: angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years. Chest. 1988;94:926-930.
35. Dolder MA, Oliver MF. Myocardial infarction in young men: study of risk factors in nine countries. Br Heart J. 1975;37:493-503.
36. Teng JK, Lin LJ, Tsai LM, Dwan CM, Chen JH. Acute myocardial infarction in young and very old Chinese adults: clinical characteristics and therapeutic implications. Int J Cardiol. 1994;44:29-36.
37. Gertler MM, White PD, Simon R, Gottsch LG. Long-term follow-up study of young coronary patients. Am J Med Sci. 1964;247:145-154.
38. Merrilees MA, Scott PJ, Norris RM. Prognosis after myocardial infarction: results of 15 years' follow up. BMJ. 1984;288:356-359.